Pre-leukemic clones that survive chemotherapy are linked to a higher risk of leukemia recurrence

Press brief by Klaus Metzeler, MD of the Ludwig-Maximilians University, Munich, Germany, at the 2016 Annual Meeting of the European Association of Hematology (EHA), held in Copenhagen, Denmark.

Share this video